Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 13.83 | 10.81 | 11.57 | 10.24 |
Non- Cash Items | -0.62 | -0.66 | -0.28 | -0.41 |
Changesin Working Capital | 5.20 | 3.20 | 0.49 | -8.11 |
Cashfrom Operating Activities | 18.41 | 13.22 | 11.23 | 1.33 |
Capital Expenditures | -13.20 | -9.30 | -5.25 | -1.67 |
Other Investing Cash Flow Items Total | -0.02 | 0.66 | 0.27 | 0.42 |
Cashfrom Investing Activities | -13.22 | -8.64 | -4.97 | -1.25 |
Financing Cash Flow Items | -4.87 | -3.94 | -2.91 | -3.19 |
Issuance( Retirement)of Debt Net | -0.78 | 0.17 | -2.71 | 3.33 |
Cashfrom Financing Activities | -5.65 | -3.77 | -5.62 | 0.13 |
Net Changein Cash | -0.46 | 0.81 | 0.64 | 0.21 |
Cash Interest Paid | 4.91 | 3.93 | 2.85 | 3.31 |
Cash Taxes Paid | 1.02 | 1.02 | 1.23 | 1.19 |
Deferred Taxes | - | -1.32 | -5.49 | -3.90 |
Godavari Drugs Dividend Godavari Drugs Bonus Godavari Drugs News Godavari Drugs AGM Godavari Drugs Rights Godavari Drugs Splits Godavari Drugs Board Meetings Godavari Drugs Key Metrics Godavari Drugs Shareholdings Godavari Drugs Profit Loss Godavari Drugs Balance Sheet Godavari Drugs Q1 Results Godavari Drugs Q2 Results Godavari Drugs Q3 Results Godavari Drugs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks